PPIST13226
Protein Information
| Protein_Chain | A |
|---|---|
| Protein_Sequence | GSHMASMNSEILNNIILNLRYKDNNLIDLSGYGAKVEVYDGVELNDKNQFKLTSSANSKIRVTQNQNIIFNSVFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNSGWKISIRGNRIIWTLIDINGKTKSVFFEYNIREDISEYINRWFFVTITNNLNNAKIYINGKLESNTDIKDIREVIANGEIIFKLDGDIDRTQFIWMKYFSIFNTELSQSNIEERYKIQSYSEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSPVGEILTRSKYNQNSKYINYRDLYIGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYTYKYFKKEEEKLFLAPISDSDEFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGWWFEEYKDYFCISKWYLKEVKRKPYNLKLGCNWQFIPKDEGWTE |
Peptide Information
| Peptide_Chain | B[auth S] |
|---|---|
| Peptide_Sequence | GEGKEDAFSKLKEKFMNELHK |
| Peptide_Length | 21 |
| Non-standard residues | No |
Interaction Information
| PDB_ID | 6QNS |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 2.40 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Characterization of a membrane binding loop leads to engineering botulinum neurotoxin B with improved therapeutic efficacy. |
|---|---|
| Release_Year | 2020 |
| PMID | 32182233 |
| DOI | 10.1371/journal.pbio.3000618 |